Martek Pursues Cheaper DHA Cost Structure To Give Ingredient Wider Appeal
This article was originally published in The Tan Sheet
Executive Summary
Martek Biosciences is working toward substantially lowering the cost of making docosahexaenoic acid (DHA) through a business venture with a genetics seed company